Redesigned CRISPR Gene Editing Tool Is 4,000 Times Less Error-Prone
CRISPR gene editing holds huge promise for tackling a wide range of inherited diseases, but concerns about unintended “off target” effects has slowed its rollout. A redesigned CRISPR system could finally have a practical solution to this problem. Last month, biomedical company Intellia reported promising results from a phase one trial of a CRISPR therapy […]